C42H54N10O18S4
Neat
1115.19
947692-16-2; Cefpodoxime Proxetil 4, 7-seco-Dimer; 5ASX8BNW7D; UNII-5ASX8BNW7D; Cefpodoxime proxetil impurity H [EP]; CEFPODOXIME PROXETIL IMPURITY H [EP IMPURITY]; (6R, 7R)-1-((Isopropoxycarbonyl)oxy)ethyl 7-((Z)-2-(2-((2R)-2-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-((2R)-4-((1-((isopropoxycarbonyl)oxy)ethoxy)carbonyl)-5-(methoxymethyl)-3, 6-dihydro-2H-1 and 3-thiazin-2-yl)acetamido)thiazol-4-yl)-2-(
1-propan-2-yloxycarbonyloxyethyl (6R, 7R)-7-[[(2Z)-2-[2-[[(2R)-2-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-[(2R)-5-(methoxymethyl)-4-(1-propan-2-yloxycarbonyloxyethoxycarbonyl)-3, 6-dihydro-2H-1, 3-thiazin-2-yl]acetyl]amino]-1 and 3-thiazol-4-yl]-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI=1S/C42H54N10O18S4/c1-17(2)65-41(59)69-19(5)67-37(57)25-21(11-61-7)13-71-34(48-25)28(46-31(53)26(50-63-9)23-15-73-39(43)44-23)33(55)49-40-45-24(16-74-40)27(51-64-10)32(54)47-29-35(56)52-30(22(12-62-8)14-72-36(29)52)38(58)68-20(6)70-42(60)66-18(3)4/h15-20,28-29,34,36,48H,11-14H2,1-10H3,(H2,43,44)(H,46,53)(H,47,54)(H,45,49,55)/b50-26-,51-27-/t19?,20?,28-,29-,34-,36-/m1/s1